Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana E Vanderwall

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMC Genomics|January 8, 2011
Disclosing ambiguous gene aliases by automatic literature profilingRoney S Coimbra, Dana E Vanderwall, Guilherme C Oliveira
Drug Discovery Today|April 8, 2021
Coming of age of Allotrope: Proceedings from the Fall 2020 Allotrope ConnectTodd Millecam, Austin J Jarrett, Naomi Young, et al.
Drug Discovery Today|July 31, 2021
Self-reporting data assets and their representation in the pharmaceutical industryDennis Della Corte, Wolfgang Colsman, Heiko Fessenmayr, et al.
Nucleic Acids Research|November 16, 2002
Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalationWei Wu, Dana E Vanderwall, Christopher J Turner, et al.
Journal of Molecular Biology|March 9, 2004
Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipramRobert X Xu, Warren J Rocque, Millard H Lambert, et al.
Drug Discovery Today|May 24, 2011
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experienceDana E Vanderwall, Nancy Yuen, Mohammad Al-Ansari, et al.
Molecular Endocrinology (Baltimore, Md.)|February 21, 2004
Correlation between in vitro peptide binding profiles and cellular activities for estrogen receptor-modulating compoundsMarie A Iannone, Catherine A Simmons, Sue H Kadwell, et al.
Nature|May 21, 2010
Thousands of chemical starting points for antimalarial lead identificationFrancisco-Javier Gamo, Laura M Sanz, Jaume Vidal, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinasesEdgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Genomics|January 8, 2011
Disclosing ambiguous gene aliases by automatic literature profilingRoney S Coimbra, Dana E Vanderwall, Guilherme C Oliveira
Drug Discovery Today|April 8, 2021
Coming of age of Allotrope: Proceedings from the Fall 2020 Allotrope ConnectTodd Millecam, Austin J Jarrett, Naomi Young, et al.
Drug Discovery Today|July 31, 2021
Self-reporting data assets and their representation in the pharmaceutical industryDennis Della Corte, Wolfgang Colsman, Heiko Fessenmayr, et al.
Nucleic Acids Research|November 16, 2002
Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalationWei Wu, Dana E Vanderwall, Christopher J Turner, et al.
Journal of Molecular Biology|March 9, 2004
Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipramRobert X Xu, Warren J Rocque, Millard H Lambert, et al.
Drug Discovery Today|May 24, 2011
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experienceDana E Vanderwall, Nancy Yuen, Mohammad Al-Ansari, et al.
Molecular Endocrinology (Baltimore, Md.)|February 21, 2004
Correlation between in vitro peptide binding profiles and cellular activities for estrogen receptor-modulating compoundsMarie A Iannone, Catherine A Simmons, Sue H Kadwell, et al.
Nature|May 21, 2010
Thousands of chemical starting points for antimalarial lead identificationFrancisco-Javier Gamo, Laura M Sanz, Jaume Vidal, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinasesEdgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Pageof 1